Investment Criteria

ProQuest Investments invests in companies and technologies with the potential to become substantial, sustainable enterprises. We target companies with breakthrough technology and products, proven management, large market potential, and a realizable business strategy. As a result of investing across a diversity of sectors and stages, our average investments range from $250,000 to $25,000,000.


We look for breakthrough technologies and products that have the potential to revolutionize drug discovery, patient treatment, and healthcare delivery. Strong intellectual property is a critical component.
We invest in people with a demonstrated track record of success, exceptional leadership, and the commitment to grow the company into a substantial enterprise.
We focus on opportunities in initial addressable markets of at least $200 million where there is a significant unmet need for the company's products and technology.
We support teams with a clear strategy of product development, launch and revenue building. They should demonstrate an executable roadmap to substantial value creation, key milestones required to achieve their goal, and the capital required along the way.